Penfluridol, > = 98 %( HPLC), poudre

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Penfluridol has been used as an antipsychotic agent:to study its antimetastatic effect on triple-negative breast cancer cellsto study its effects on the growth of glioblastoma cell lines,to study its effects on the vascular endothelial growth factor (VEGF)-induced angiogenesis in human umbilical vein endothelial cells (HUVECs)

Biochem/physiol Actions

T-type Ca²⁺ channel blocker; antipsychotic

Penfluridol is studied in the treatment of schizophrenia, Tourette syndrome and acute psychosis. It also exhibits anticancer activity.

Features and Benefits

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

50 mg in glass bottle